498
Views
15
CrossRef citations to date
0
Altmetric
Review

Biologics in severe asthma: the overlap endotype - opportunities and challenges

, , &
Pages 1427-1434 | Received 16 Jun 2020, Accepted 10 Aug 2020, Published online: 25 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Francesco Menzella, Matteo Fontana, Marco Contoli, Patrizia Ruggiero, Carla Galeone, Silvia Capobelli, Anna Simonazzi, Chiara Catellani, Chiara Scelfo, Claudia Castagnetti, Francesco Livrieri & Nicola Facciolongo. (2022) Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life. Journal of Asthma and Allergy 15, pages 505-515.
Read now
Agamemnon Bakakos & Anastasia Krompa. (2022) Asthma in the era of SARS CoV-2 virus. Journal of Asthma 59:8, pages 1501-1508.
Read now
Agamemnon Bakakos, Nikoletta Rovina, Stelios Loukides & Petros Bakakos. (2022) Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences. Expert Opinion on Biological Therapy 22:7, pages 855-870.
Read now
Maria De Filippo, Martina Votto, Amelia Licari, Fabio Pagella, Marco Benazzo, Giorgio Ciprandi & Gian Luigi Marseglia. (2021) Novel therapeutic approaches targeting endotypes of severe airway disease. Expert Review of Respiratory Medicine 15:10, pages 1303-1316.
Read now

Articles from other publishers (11)

Jiyeon Kim, Do Hyun Kim & Se Hwan Hwang. (2023) Effectiveness of Dupilumab Treatment to Treat Chronic Rhinosinusitis With Nasal Polyposis: A Systematic Review and Meta-Analysis. Journal of Rhinology 30:2, pages 62-68.
Crossref
Grzegorz Kardas, Michał Panek, Piotr Kuna, Piotr Damiański & Maciej Kupczyk. (2022) Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives. Frontiers in Immunology 13.
Crossref
Francesco Menzella, Andrea Ballarin, Maria Sartor, Ariel Fabian Floriani, Lorenzo Corsi, Cristina Dartora, Silvia Tonin & Micaela Romagnoli. (2022) Comparison between clinical trials and real-world evidence studies on biologics for severe asthma. Journal of International Medical Research 50:11, pages 030006052211336.
Crossref
Cristiano Caruso, Paolo Cameli, Elena Altieri, Maria Aliani, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Stefano Centanni, Maria D’Amato, Stefano Del Giacco, Fausto De Michele, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Marco Caminati, Alessandra Vultaggio, Alessandro Zullo, Sara Rizzoli, Silvia Boarino, Gianfranco Vitiello, Francesco Menzella & Fabiano Di Marco. (2022) Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis. Frontiers in Medicine 9.
Crossref
Roland Buhl, Elisabeth Bel, Arnaud Bourdin, Ignacio Dávila, Jo A. Douglass, J. Mark FitzGerald, David J. Jackson, Njira L. Lugogo, Andrea Matucci, Ian D. Pavord, Michael E. Wechsler & Monica Kraft. (2022) Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion. The Journal of Allergy and Clinical Immunology: In Practice 10:2, pages 422-432.
Crossref
Safwat Eldaboussi, Ahmed Qabil, Ahmed Lotfi, Amgad Awad, Eman Abdel Salam, Abdullah Alkhamis & Usama E. Abuelhassan. (2021) Saudi Arabian real-life experience with biologic therapy in severe asthma. Multidisciplinary Respiratory Medicine 16.
Crossref
Corrado Pelaia, Claudia Crimi, Santi Nolasco, Giovanna Elisiana Carpagnano, Raffaele Brancaccio, Enrico Buonamico, Raffaele Campisi, Claudia Gagliani, Vincenzo Patella, Girolamo Pelaia, Giuseppe Valenti & Nunzio Crimi. (2021) Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy. Biomedicines 9:12, pages 1822.
Crossref
Mohamad Chebbo, Catherine Duez, Marie C. Alessi, Pascal Chanez & Delphine Gras. (2021) Platelets: a potential role in chronic respiratory diseases?. European Respiratory Review 30:161, pages 210062.
Crossref
Agamemnon Bakakos, Nikoleta Rovina & Petros Bakakos. (2021) Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy. International Journal of Molecular Sciences 22:8, pages 3969.
Crossref
Andriana I. Papaioannou, Evangelia Fouka, Despina Papakosta, Spyridon Papiris & Stelios Loukides. (2020) Switching between biologics in severe asthma patients. When the first choice is not proven to be the best. Clinical & Experimental Allergy 51:2, pages 221-227.
Crossref
Youngsoo LeeQuang Luu QuocHae-Sim Park. (2021) Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies. Allergy, Asthma & Immunology Research 13:3, pages 375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.